Submitted by Anonymous (not verified) on 28 November 2024 - 13:13
Human medicines European public assessment report (EPAR): Xultophy, insulin degludec,liraglutide, Date of authorisation: 18/09/2014, Revision: 19, Status: Authorised
Source:
